Lyfebulb Partners with UnitedHealth Group to Support Patient-Driven Innovations for People with Inflammatory Bowel Disease

Go back to Lyfebulb Partners with UnitedHealth Group to Support Patient-Driven Innovations for People with Inflammatory Bowel Disease

UnitedHealth Group (UNH) PT Raised to $260 at Oppenheimer Following 4Q

January 17, 2018 9:37 AM EST

Oppenheimer raised its price target on UnitedHealth Group (NYSE: UNH) to $260.00 (from $240.00) while maintaining a Outperform rating following the company's 4Q earnings report. UNH reported 4Q17 adj. EPS of $2.59 vs. the Street's estimates of $2.51. The key topic of discussion was the impact of... More